Group B Streptococcus Colonization among Pregnant Women Attending Antenatal Care at Tertiary Hospital in Rural Southwestern Uganda

listen audio

Study Justification:
– The study aimed to determine the prevalence and factors associated with group B streptococcal anogenital colonization among pregnant women attending antenatal care at a tertiary hospital in rural southwestern Uganda.
– This information is important for understanding the burden of group B streptococcus (GBS) colonization in this population and identifying potential risk factors.
– The findings can help inform strategies for prevention and management of GBS colonization during pregnancy, ultimately reducing the risk of adverse outcomes for both mothers and infants.
Study Highlights:
– The study included 309 pregnant women at ≥35 weeks of gestation attending antenatal clinic at Mbarara Regional Referral Hospital.
– The prevalence of GBS colonization among these women was found to be 28.8%.
– Obesity was the only significant factor associated with anogenital GBS colonization.
– Maternal age, educational level, residence, and gravidity were not found to be associated with GBS colonization.
– These findings suggest that obesity may be an important risk factor for GBS colonization among pregnant women in this population.
Recommendations for Lay Reader:
– Pregnant women should be aware of the risk of GBS colonization and its potential impact on pregnancy outcomes.
– Maintaining a healthy weight during pregnancy may help reduce the risk of GBS colonization.
– Regular antenatal care visits and screening for GBS colonization can help identify and manage cases effectively.
– Further research is needed to explore other potential risk factors for GBS colonization and to develop targeted interventions for prevention.
Recommendations for Policy Maker:
– Strengthen antenatal care services in rural areas to ensure regular screening and management of GBS colonization among pregnant women.
– Develop and implement educational programs to raise awareness about GBS colonization and its prevention strategies among healthcare providers and pregnant women.
– Consider incorporating obesity prevention and management programs into antenatal care services to reduce the risk of GBS colonization.
– Allocate resources for research and surveillance to monitor the prevalence and trends of GBS colonization in the population.
Key Role Players:
– Healthcare providers (doctors, nurses, midwives) for antenatal care and GBS screening.
– Laboratory technologists for processing and analyzing GBS samples.
– Researchers and epidemiologists for conducting further studies and monitoring GBS colonization trends.
– Policy makers and government officials responsible for implementing and funding interventions related to GBS colonization.
Cost Items for Planning Recommendations:
– Training and capacity building for healthcare providers on GBS screening and management.
– Procurement of GBS test kits and laboratory equipment for sample processing.
– Development and dissemination of educational materials for healthcare providers and pregnant women.
– Research funding for further studies on GBS colonization and its prevention strategies.
– Infrastructure and resource allocation for strengthening antenatal care services in rural areas.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong. The study design is cross-sectional, which limits the ability to establish causation. However, the study had a relatively large sample size and used a standardized testing method. To improve the evidence, future studies could consider using a longitudinal design to establish temporal relationships between factors and GBS colonization. Additionally, including a control group of non-pregnant women could provide a better comparison. Finally, conducting the study at multiple hospitals or in different regions could increase the generalizability of the findings.

Objectives. This study sought to determine the prevalence and factors associated with group B streptococcal anogenital colonization among pregnant women attending antenatal care at Mbarara Regional Referral Hospital, a tertiary hospital. Methods. Cross-sectional study where 309 pregnant women ≥ thirty-five weeks of gestation attending antenatal clinic were consecutively recruited between January and March 2015. Anovaginal swabs were collected and tested qualitatively using rapid visual immunoassay GBS test kits for presence of GBS antigens. Data was analyzed using STATA version 12. In univariate analysis, GBS colonized mothers were presented as percentages and numbers, and in multivariate analysis logistic regression analysis was applied to determine the associations of exposure variable and GBS colonization; a value of less than 0.05 was considered significant. Results. Mothers’ median age was 25 years, 14.6% mothers being obese. GBS prevalence was 28.8%, 95% CI: 23.7-33.9. Obesity was the only significant factor associated with anogenital GBS colonization with odds ratio of 3.78, 95% CI: 1.78-8.35, a p value of 0.001. Maternal ages, educational level, residence, and gravidity were not associated with GBS anogenital colonization. Conclusion. Group B streptococcal anogenital colonization among pregnant women attending antenatal care at tertiary hospital, in Southwestern Uganda, is high.

This was a cross-sectional study among pregnant women at ≥35 weeks of gestation, attending antenatal clinic at Mbarara Regional Referral Hospital conducted over a period of 3 months between January and March 2015. Mothers who were at ≥35 weeks of gestation and had consented to participate were included while those who had been on antibiotics treatment within the last two weeks prior to study were excluded. Participants were recruited using a consecutive sampling technique until the sample size was achieved. The principal investigator reviewed the antenatal cards of the antenatal clients as they came to the observation area for blood pressure and weight measurements. Using each participant’s last normal menstruation period, weeks of gestation were calculated using Naegele’s formula. Those at ≥35 weeks of gestation had an informed consent sought; those willing to participate in the study then signed or thumbprinted on the consent form. A pretested questionnaire was then administered, physical examination was performed, and anogenital specimen was collected using a Dacron swab. Participant’s sociodemographic data, history of current pregnancy, previous miscarriages, preterm labor, and stillbirths data were gathered. A general physical examination, obstetrical examination, collection of study samples, and completion of the routine ANC visit for that day followed. The swabs were collected as follows; after additional counseling prior to collection of anogenital samples, the principal investigator wore a pair of latex gloves and, in the presence of a female nurse as a chaperone, asked the mother to lie in the dorsal position. While at the foot of the bed the study principal investigator, with the help of a research assistant, would examine the external genitalia and vaginal introitus, after separation of the labia. One sealed sterile swab was used to swab the lower vagina (without speculum placement) and a second sealed sterile swab was used to swab the anal canal. The swabs were then labeled and immediately processed in the clinic by the principal investigator with the assistance of a research assistant according to the manufacturer’s instructions (Safecare Biotech, (Hangzhou) Co., Ltd.) Specimens, reagents, and/or controls were processed at room temperature (15–30°C): The rapid strep B test kit was removed from its sealed pouch and placed on a clean level surface. The device was labeled at this point with patient or control identification. The assay was performed within 10 minutes of swab collection. Three drops (approximately 120 μL) of extracted solution from the extraction tube were added to the sample well on the test device. Trapping air bubbles in the specimen well (S) was avoided, and no solution was added to the observation window. After ten minutes of waiting for the appearance of colored band(s), results were read and interpreted as follows: Mothers were given their results 20 minutes after picking their anogenital swabs and those who tested positive for GBS were counseled about the result and indicated on their antenatal care card to act as notification to their primary care obstetricians. Those who tested GBS negative were given their results and discharged from the study. To avoid double recruitment a GBS+ signature was put onto the antenatal care card of the client indicating that the client was a participant in the GBS study. Results were stored by the principal investigator with limited access for other personnel. Data was collected using a pretested, coded questionnaire to gather sociodemographic and other relevant history data and findings on physical examination. The antenatal profiles, such as HIV status, were collected from patients’ files/antenatal cards while results of anogenital specimens were obtained from the laboratory request forms. Data collection tools were initially piloted on 50 participants and adjustments were made accordingly in consultation with the study team. These were not included in final analysis. Data was collected by the principal investigator and trained research assistants. The dependent variable was maternal GBS anogenital colonization at MRRH while independent variables were constituted by information collected on socio demographics, obstetrical factors like gravidity, history of early neonatal febrile illness or death, prolonged rupture of membranes, preterm delivery in the previous pregnancies, and other factors like HIV serostatus, BMI (calculated as weight of the mother in kilograms divided by her height in meters squared), and history of herbal medicine use during the current pregnancy. Data was entered and cleaned using Epi Info version 7, analyzed using STATA version 12, where in univariate analysis GBS colonized mothers were presented as percentages and numbers and in multivariate analysis logistic regression analysis was applied to determine the associations of exposure variable and GBS colonization, and a value of less than 0.05 was considered significant. A pretested questionnaire was used to collect data. Every 20th test kit was read by a laboratory technologist from the Department of Microbiology, MUST, who was not part of the study. We obtained informed consent and the study was approved by Mbarara University of Science and Technology institutional review board.

N/A

Based on the provided description, here are some potential innovations that can be used to improve access to maternal health:

1. Telemedicine: Implementing telemedicine services can allow pregnant women in rural areas to access antenatal care remotely. This would involve using technology such as video conferencing to connect pregnant women with healthcare providers for consultations, monitoring, and follow-up.

2. Mobile health (mHealth) applications: Developing mobile applications specifically designed for maternal health can provide pregnant women with access to information, reminders, and resources related to their pregnancy. These apps can also include features for tracking symptoms, appointments, and medication adherence.

3. Community health workers: Training and deploying community health workers in rural areas can help bridge the gap in access to maternal health services. These workers can provide education, counseling, and basic antenatal care services to pregnant women in their communities.

4. Point-of-care testing: Introducing rapid diagnostic tests for conditions such as Group B Streptococcus (GBS) colonization can improve access to timely and accurate diagnosis. These tests can be performed at the point of care, reducing the need for samples to be sent to a laboratory and allowing for immediate initiation of appropriate treatment.

5. Health information systems: Implementing electronic health records and health information systems can improve the coordination and continuity of care for pregnant women. This can ensure that relevant information is easily accessible to healthcare providers, regardless of the location of the patient.

6. Mobile clinics: Setting up mobile clinics that travel to remote areas can bring antenatal care services closer to pregnant women who may have limited access to healthcare facilities. These clinics can provide comprehensive antenatal care, including screenings, vaccinations, and counseling.

7. Public-private partnerships: Collaborating with private healthcare providers and organizations can help expand access to maternal health services in underserved areas. This can involve leveraging existing infrastructure, resources, and expertise to reach more pregnant women and improve the quality of care.

It is important to note that the specific recommendations for improving access to maternal health should be based on a comprehensive assessment of the local context, resources, and needs of the target population.
AI Innovations Description
Based on the description provided, the following recommendation can be developed into an innovation to improve access to maternal health:

1. Strengthening Antenatal Care Services: Based on the study findings, it is important to focus on improving antenatal care services, particularly in rural areas. This can be done by increasing the availability and accessibility of antenatal clinics, ensuring that pregnant women receive regular check-ups, and providing comprehensive care that includes screening for Group B Streptococcus (GBS) colonization.

2. Training Healthcare Providers: Healthcare providers should be trained on the importance of GBS screening and the appropriate methods for collecting and testing anogenital swabs. This will ensure accurate and reliable results, leading to appropriate management and treatment of GBS colonization.

3. Implementing Rapid Diagnostic Tests: The study utilized rapid visual immunoassay GBS test kits for qualitative detection of GBS antigens. This type of rapid diagnostic test can be further developed and implemented in maternal health settings to improve access to GBS screening. These tests are easy to use, provide quick results, and can be performed at the point of care, reducing the need for laboratory infrastructure.

4. Integrating GBS Screening into Routine Antenatal Care: GBS screening should be integrated into routine antenatal care services to ensure that all pregnant women are screened for GBS colonization. This can be done by incorporating GBS screening into existing antenatal care protocols and guidelines, and ensuring that healthcare providers are aware of the importance of GBS screening and its implications for maternal and neonatal health.

5. Education and Counseling: Pregnant women should be educated about the importance of GBS screening and its potential impact on maternal and neonatal health. Counseling sessions can be conducted during antenatal visits to provide information about GBS colonization, its transmission, and the available treatment options. This will empower pregnant women to make informed decisions regarding their healthcare and the health of their babies.

6. Collaboration and Partnerships: Collaboration between healthcare providers, researchers, policymakers, and community organizations is essential to develop and implement innovative strategies to improve access to maternal health. Partnerships can help in mobilizing resources, sharing best practices, and advocating for policy changes that prioritize maternal health and GBS screening.

By implementing these recommendations, access to maternal health can be improved, leading to better outcomes for both mothers and babies.
AI Innovations Methodology
Based on the provided information, here are some potential recommendations to improve access to maternal health:

1. Strengthen Antenatal Care (ANC) Services: Enhance the quality and availability of ANC services by ensuring that pregnant women receive comprehensive care, including regular check-ups, screenings, and education on maternal health.

2. Increase Awareness and Education: Implement community-based programs to raise awareness about the importance of maternal health and the risks associated with conditions like Group B Streptococcus (GBS) colonization. Provide education on preventive measures and early detection.

3. Improve Testing and Diagnosis: Enhance the availability and accessibility of GBS testing kits in healthcare facilities to enable early detection and appropriate management of GBS colonization among pregnant women.

4. Strengthen Referral Systems: Establish effective referral systems between primary healthcare centers and tertiary hospitals to ensure that pregnant women with high-risk conditions, such as GBS colonization, receive timely and appropriate care.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the Baseline: Collect data on the current state of access to maternal health services, including the prevalence of GBS colonization and the utilization of ANC services in the target population.

2. Define the Intervention: Determine the specific interventions to be implemented, such as strengthening ANC services, increasing awareness and education, improving testing and diagnosis, and strengthening referral systems.

3. Collect Data: Gather data on the implementation of the interventions, including the number of pregnant women accessing ANC services, the number of GBS tests conducted, and the number of referrals made.

4. Analyze Data: Use statistical analysis to assess the impact of the interventions on access to maternal health. Compare the baseline data with the data collected after the implementation of the interventions to determine any changes in GBS colonization rates, ANC utilization, and referral rates.

5. Evaluate Results: Evaluate the results of the analysis to determine the effectiveness of the interventions in improving access to maternal health. Assess whether the recommendations have led to a reduction in GBS colonization rates, increased utilization of ANC services, and improved referral rates.

6. Adjust and Refine: Based on the evaluation results, make any necessary adjustments or refinements to the interventions to further improve access to maternal health.

By following this methodology, it is possible to simulate the impact of the recommendations on improving access to maternal health and make informed decisions on implementing the most effective interventions.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email